National Health Research Institutes, Taiwan
Clinical trials sponsored by National Health Research Institutes, Taiwan, explained in plain language.
-
Double vs. single immunotherapy: new hope for Tough-to-Treat bile duct cancer?
Disease control Not yet recruitingThis study is testing if adding a second immunotherapy drug (relatlimab) to a standard treatment improves outcomes for adults with advanced bile duct cancer who haven't had prior treatment. About 76 participants will be randomly assigned to receive either the two-drug immunothera…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for liver cancer patients when first treatment fails
Disease control Not yet recruitingThis study is testing the drug cabozantinib for people with advanced liver cancer (hepatocellular carcinoma) whose disease has gotten worse after standard first-line immunotherapy combinations. The main goals are to see if the drug can control the cancer for at least 6 months and…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Can online therapy ease anxiety and depression from home?
Symptom relief Not yet recruitingThis study is testing whether an 8-week online therapy program can help reduce symptoms of anxiety and depression in adults. Participants will be randomly assigned to receive either their usual care alone or their usual care plus the online program. The goal is to see if this con…
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC